Protagonist Therapeutics Inc (PTGX)

41.04 -1.63 (-3.82%) USD  |  NASDAQ  |  Nov 14, 16:00
41.51 +0.47 (+1.15%) After-Hours: 07:38
More

Protagonist Therapeutics Cash and Short Term Investments (Quarterly): 468.72M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2015. Upgrade now.
Date Value
September 30, 2024 468.72M
June 30, 2024 564.00M
March 31, 2024 322.64M
December 31, 2023 341.62M
September 30, 2023 320.75M
June 30, 2023 313.40M
March 31, 2023 230.76M
December 31, 2022 237.36M
September 30, 2022 267.44M
June 30, 2022 291.89M
March 31, 2022 305.29M
December 31, 2021 326.90M
September 30, 2021 314.30M
June 30, 2021 354.28M
March 31, 2021 273.48M
December 31, 2020 305.81M
September 30, 2020 193.97M
June 30, 2020 208.66M
Date Value
March 31, 2020 117.51M
December 31, 2019 133.02M
September 30, 2019 137.69M
June 30, 2019 126.10M
March 31, 2019 112.55M
December 31, 2018 128.85M
September 30, 2018 138.52M
June 30, 2018 125.17M
March 31, 2018 134.96M
December 31, 2017 144.00M
September 30, 2017 93.59M
June 30, 2017 64.49M
March 31, 2017 63.25M
December 31, 2016 77.60M
September 30, 2016 98.52M
June 30, 2016 20.18M
March 31, 2016 29.02M
December 31, 2015 11.92M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

117.51M
Minimum
Mar 2020
564.00M
Maximum
Jun 2024
294.59M
Average
305.55M
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Johnson & Johnson 20.30B
Assembly Biosciences Inc 109.22M
Precision BioSciences Inc 101.20M
Entrada Therapeutics Inc 449.34M
NovaBay Pharmaceuticals Inc 0.776M